Bernstein Bradford E's Form 4 filing
Enfusion, Inc. (ENFN) · filed Apr 21, 2022
- Accession no.
- 0001104659-22-048465
- Filed
- Apr 21, 2022, 5:30 PM ET
- Trade date
- Oct 25, 2021
- Filing delay
- 178 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $64.8M. It was filed 178 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bernstein Bradford ECIK 0001373735 | Director, 10% Owner |
| FTV IV, L.P.CIK 0001560793 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 25, 2021 | Class A Common Stock | SSaleDisposed | −4,075,531 | $15.90 | −$64,780,565.25 | 31,297,606 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.